drugset / Trial / NCT00805233
Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
RandomizedParallel-groupOpen-labelTreatment
Summary
This open-label, randomized, Phase II research study will look to see whether an investigational treatment combining bromfenac ophthalmic drops with ranibizumab intravitreal injection is safe and effective for treating wet AMD as compared to ranibizumab alone.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | — | Other |
| Subject | Ranibizumab | Monoclonal antibody | — | Intravitreal |